<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-naproxen.xml</id>
  <title>Recalls Watch: Naproxen</title>
  <link rel="self" href="https://recalls.watch/feed/substance-naproxen.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-05-13T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/98781/</id>
    <title>Acella Pharmaceuticals, LLC: NAPROXEN ORAL SUSPENSION</title>
    <link href="https://recalls.watch/recall/fda/98781/"/>
    <updated>2026-05-13T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Chemical contamination; presence of lead and lithium above specification</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96474/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Fenofibrate Capsules 67 mg and 38 more</title>
    <link href="https://recalls.watch/recall/fda/96474/"/>
    <updated>2025-04-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93368/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Indomethacin 25mg Capsules and 1 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93368"/>
    <updated>2023-12-06T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/65360/</id>
    <title>Lowlite Investments, Inc. D/B/A Olympia Pharmacy: Acetyl-D-Glucosamine w/Chondroitin 200 mg/ml and 104 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=65360"/>
    <updated>2013-07-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes</summary>
  </entry>
</feed>
